Sterling Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.9M | Sell |
178,425
-93,473
| -34% | -$20.1M | 0.76% | 23 |
|
|
2026
Q1 | $59.1M | Sell |
271,898
-3,843
| -1% | -$852K | 1.12% | 14 |
|
|
2025
Q4 | $63M | Sell |
275,741
-140,446
| -34% | -$32M | 1.02% | 16 |
|
|
2025
Q3 | $96.4M | Sell |
416,187
-51,030
| -11% | -$10.4M | 1.41% | 13 |
|
|
2025
Q2 | $86.7M | Buy |
467,217
+21,283
| +5% | +$3.96M | 1.23% | 17 |
|
|
2025
Q1 | $93.4M | Sell |
445,934
-25,179
| -5% | -$4.89M | 1.45% | 18 |
|
|
2024
Q4 | $83.7M | Sell |
471,113
-253,534
| -35% | -$46.6M | 1.15% | 21 |
|
|
2024
Q3 | $143M | Buy |
+724,647
| New | +$135M | 1.85% | 14 |
|
|
2019
Q3 | $98.5M | Buy |
1,301,199
+106,742
| +9% | +$7.32M | 0.93% | 20 |
|
|
2019
Q2 | $86.9M | Buy |
1,194,457
+45,403
| +4% | +$3.57M | 0.84% | 28 |
|
|
2019
Q1 | $92.6M | Buy |
1,149,054
+10,622
| +0.9% | +$869K | 0.92% | 21 |
|
|
2018
Q4 | $105M | Buy |
1,138,432
+4,977
| +0.4% | +$438K | 1.14% | 9 |
|
|
2018
Q3 | $107M | Sell |
1,133,455
-4,036
| -0.4% | -$383K | 0.97% | 16 |
|
|
2018
Q2 | $105M | Buy |
1,137,491
+1,168
| +0.1% | +$114K | 0.98% | 16 |
|
|
2018
Q1 | $108M | Sell |
1,136,323
-185,483
| -14% | -$20.4M | 1.01% | 13 |
|
|
2017
Q4 | $128M | Sell |
1,321,806
-86,184
| -6% | -$8.12M | 1.16% | 9 |
|
|
2017
Q3 | $125M | Sell |
1,407,990
-94,029
| -6% | -$7.16M | 1.18% | 9 |
|
|
2017
Q2 | $109M | Buy |
1,502,019
+11,813
| +0.8% | +$794K | 1.05% | 15 |
|
|
2017
Q1 | $97.1M | Sell |
1,490,206
-93,154
| -6% | -$5.86M | 0.91% | 31 |
|
|
2016
Q4 | $99.2M | Sell |
1,583,360
-1,681
| -0.1% | -$103K | 0.89% | 32 |
|
|
2016
Q3 | $100M | Sell |
1,585,041
-150,139
| -9% | -$9.72M | 0.92% | 30 |
|
|
2016
Q2 | $107M | Buy |
1,735,180
+1,635
| +0.1% | +$99.6K | 0.98% | 18 |
|
|
2016
Q1 | $99M | Sell |
1,733,545
-77,041
| -4% | -$4.29M | 0.9% | 23 |
|
|
2015
Q4 | $107M | Buy |
1,810,586
+313,791
| +21% | +$18.1M | 0.95% | 19 |
|
|
2015
Q3 | $81.4M | Buy |
1,496,795
+41,766
| +3% | +$2.72M | 0.73% | 46 |
|
|
2015
Q2 | $97.8M | Sell |
1,455,029
-21,391
| -1% | -$1.4M | 0.88% | 34 |
|
|
2015
Q1 | $86.4M | Sell |
1,476,420
-105,066
| -7% | -$6.35M | 0.77% | 43 |
|
|
2014
Q4 | $103M | Buy |
1,581,486
+899,739
| +132% | +$56.7M | 0.9% | 32 |
|
|
2014
Q3 | $39.4M | Sell |
681,747
-926,989
| -58% | -$51.5M | 0.48% | 74 |
|
|
2014
Q2 | $90.8M | Buy |
1,608,736
+80,555
| +5% | +$4.23M | 0.78% | 44 |
|
|
2014
Q1 | $78.5M | Sell |
1,528,181
-12,273
| -0.8% | -$620K | 0.67% | 58 |
|
|
2013
Q4 | $81.4M | Sell |
1,540,454
-7,959
| -0.5% | -$391K | 0.75% | 52 |
|
|
2013
Q3 | $69.3M | Buy |
1,548,413
+136,510
| +10% | +$6.05M | 0.81% | 53 |
|
|
2013
Q2 | $58.4M | Buy |
+1,411,903
| New | +$61.8M | 0.72% | 61 |
|
Other funds holding ABBV
ECSS
ATO
Sterling Capital Management's ABBV Position: Q2 2026 in Review
Sterling Capital Management reduced its AbbVie (ABBV) stake by 34% in Q2 2026, selling an estimated $20.1M and leaving 178,425 shares worth $44.9M. The position accounts for 0.76% of the portfolio, ranked #23.
Sterling Capital Management first reported a position in ABBV in Q2 2013 and has held it in 34 quarters since. The position peaked at $143M in Q3 2024. 1,906 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Sterling Capital Management held 178,425 shares of AbbVie worth $44.9M as of Q2 2026.
- Sterling Capital Management sold 93,473 AbbVie shares in Q2 2026, an estimated $20.1M.
- AbbVie made up 0.76% of Sterling Capital Management's portfolio in Q2 2026, its #23 holding.
- Sterling Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 34 quarters since.
- Sterling Capital Management's AbbVie position peaked at $143M in Q3 2024.
- 1,906 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.